Your browser doesn't support javascript.
loading
Severe hypertrophic cardiomyopathy in a patient with a homozygous MYH7 gene variant.
Serra, Walter; Vitetta, Giulia; Uliana, Vera; Barocelli, Federico; Barili, Valeria; Allegri, Isabella; Ardissino, Diego; Gualandi, Francesca; Percesepe, Antonio.
Afiliação
  • Serra W; Cardiology Division, University Hospital of Parma, Italy.
  • Vitetta G; Medical Genetics Unit, University Hospital of Parma, Italy.
  • Uliana V; Medical Genetics Unit, University Hospital of Parma, Italy.
  • Barocelli F; Cardiology Division, University Hospital of Parma, Italy.
  • Barili V; Medical Genetics, Department of Medicine and Surgery, University of Parma, Italy.
  • Allegri I; Neurology Unit, University Hospital of Parma, Italy.
  • Ardissino D; Cardiology Division, University Hospital of Parma, Italy.
  • Gualandi F; Medical Genetics Service, Department of Mother and Child, University Hospital S. Anna, Ferrara, Italy.
  • Percesepe A; Medical Genetics, Department of Medicine and Surgery, University of Parma, Italy.
Heliyon ; 8(12): e12373, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36593836
ABSTRACT

Background:

Hypertrophic cardiomyopathy is an autosomal dominant disease. The main feature of this disorder is its occurrence in patients who present a left ventricular hypertrophy, unexplained by the loading conditions, usually asymmetric with greatest involvement most commonly of the interventricular septum.Case presentation During a sports medicine control, a ultrasound scan in a 17 years old patient has shown a concentric left ventricular parietal hypertrophy associated with a 23 mm mid- basal interventricular septum thickness. After genetic counselling, a positive family history for hypertrophic cardiac disease and parents' consanguineity was found. The genetic basis of the hypertrophic cardiomyopathy was investigated through a dedicated gene panel. The genetic test has revealed the presence of the variant c.3424G>A (p.Glu1142Lys) in the MYH7 gene in a homozygous state. Genotyping of the parents and of the two brothers revealed the presence of the MYH7 variant in heterozygosity in both parents and in the younger brother. In all of them, variable signs of hypertrophic cardiomyopathy were found.

Conclusions:

Our findings report the presence of a homozygous variant in a sarcomeric gene (MYH7) which gave rise to early HCM, whereas the variant in a heterozygous state was associated to much milder cardiac phenotypes in the affected relatives. The onset and the progression of the hypertrophic cardiomyopathy in the reported family is to be referred to the presence of the variant in hetero- or homo-zygosity in a gene dosage manner.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article